Adlai Nortye Group Ltd. (ANL)
$13.78-$0.50 (-3.49%) Today
Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 11,667 | $165K |
| Other acquisition / disposition | 1 | 136,667 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
3 Form 4 filings on record, the earliest from May 21, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Xiaofeng Ye - Officer | Open-market sale | American Depositary Shares | 6,000 | $13.98 | $84K | |
| Xiaofeng Ye - Officer | Open-market sale | American Depositary Shares | 5,667 | $14.25 | $81K | |
| Ping Ji - Director | Other | American Depository shares | 136,667 | $0.00 | - | |
| Yang Lu - Officer | Open-market sale | American Depositary Shares | 10 | $13.18 | $132 |
Adlai Nortye Group Ltd. (ANL) had 2 insider filings in the last 90 days, with the most recent on 2026-08-26. The full record for ANL runs to 3 Form 4 filings, the earliest from 2026-05-21. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of ANL were filed in the last 90 days.
2 insider sales of ANL were filed in the last 90 days, totaling $165K.
This page tracks ANL Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ANL to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
